Overview
GJB2 encodes Connexin 26, a gap junction protein essential for potassium recirculation in the inner ear. Mutations in this gene are the most common genetic cause of congenital deafness worldwide. The 35delG mutation alone is responsible for 50-80% of all autosomal recessive deafness cases in Caucasian populations.
13q12.11 (Chromosome 13)
Hereditary Diseases
Autosomal recessive
Carrier frequency 2-4% in Europe; most common genetic cause of deafness
Function & Significance
Connexin 26 forms gap junctions (cell-to-cell channels) between the supporting cells of the cochlea in the inner ear. These channels allow the exchange of potassium ions and small molecules between neighboring cells. Potassium recirculation is essential for maintaining the endocochlear potential necessary for sound perception.
In mutations in GJB2, gap junction function is disrupted. This leads to an accumulation of potassium ions in the cochlea, which damages hair cells and leads to sensorineural hearing loss. Deafness is typically congenital (from birth) and non-progressive, but in rare cases, it can also appear later or worsen.
🔬 Gap Junctions in the Inner Ear
Gap junctions are specialized cell connections composed of connexin proteins. In the inner ear, Connexin 26 (GJB2) and Connexin 30 (GJB6) form a network that maintains potassium homeostasis. Disruptions in this system lead to the death of hair cells and thus to irreversible hearing loss.
Associated Diseases
-
👂 Non-syndromic Deafness DFNB1
Congenital sensorineural deafness without further symptoms. Severity varies from mild to profound.
-
🧒 Congenital Deafness
Deafness from birth, often bilateral (both ears) and severe to profound
-
🔊 Late-Onset Deafness
Rarer: progressive hearing loss in childhood or adulthood
-
🩺 Keratitis-Ichthyosis-Deafness Syndrome (KID)
Rare syndromic form with skin changes (only with specific mutations)
🧬 Relevant SNPs
13:20189539
/
Significance: 35delG (c.35delG) – Most common GJB2 mutation worldwide. Frameshift mutation leads to a premature stop codon and a non-functional protein. Responsible for 50-80% of all autosomal recessive deafness cases in Caucasian populations. Particularly common in Southern Europe and the Mediterranean region.
13:20189576
/
Significance: 167delT – Another common deletion, especially in Ashkenazi Jewish populations. Also leads to frameshift and non-functional protein.
⚕️ Clinical Significance
GJB2 mutations are included in newborn hearing screening in many countries. Early diagnosis is critical for language development. Affected children benefit from:
- Cochlear Implants: Very effective in GJB2-associated deafness
- Hearing Aids: For milder forms
- Early Language Support: Sign language and/or spoken language
Gene Therapy Research: Promising preclinical studies for gene therapy for GJB2 mutations are ongoing. Initial animal studies show restoration of hearing function.
Genetic Counseling: Carriers have a 25% risk per pregnancy of having a deaf child. Prenatal diagnosis is possible.
📚 Data Sources
The information on this page is based on the following scientific sources:
- OMIM: #220290 (Deafness, Autosomal Recessive 1A)
- dbSNP: rs80338939 (35delG), rs111033186 (167delT)
- ClinVar: Pathogenic GJB2 variants
- PubMed: Literature on GJB2 and congenital deafness
- Orphanet: ORPHA90635 (Autosomal recessive non-syndromic sensorineural deafness type DFNB)
- Hereditary Hearing Loss Homepage: hereditaryhearingloss.org
Last Update: February 2026
Biological Function
Associated Conditions
Analyzed Markers
35delG (c.35delG) - Most common mutation worldwide. Frameshift leads to non-functional protein. Responsible for 50-80% of profound recessive deafness in Caucasian populations.
167delT - Another common deletion, especially in Ashkenazi Jews.